Mast Therapeutics Reports Fourth Quarter and Full Year 2012 Financial Results

March 19, 2013 |

1 min read

SAN DIEGO, March 19, 2013 /PRNewswire/ -- Mast Therapeutics, Inc. (NYSE MKT: MSTX) today reported financial results for the fourth quarter and year ended December 31, 2012.

Earnings

MORE ON THIS TOPIC

Rheumatoid arthritis (RA) commonly causes inflammation in the hands, leading to pain, swelling, and stiffness in the joints, particularly the small joints of the fingers and wrists. This inflammation results from the immune system attacking the body's own joint tissues, causing the synovium (lining of the joint) to become inflamed and release chemicals that damage nearby tissues.

Mergers & acquisitions

Sobi Makes $1.5B Gout Play With Arthrosi Acquisition

December 15, 2025

·

2 min read

·

Tristan Manalac

Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant

Layoff Tracker

Pfizer, Geron Downsize To Streamline Costs

December 12, 2025

·

95 min read

·

BioSpace Editorial Staff

Creative collage illustration of financial business. Two businessmen shaking hands for partners agreement. Conceptual illustration of success deal, corporate ethic, connection.

Weight loss

Zealand Bets up to $2.5B in Metabolic Pact With Chinese Biotech

December 11, 2025

·

2 min read

·

Tristan Manalac

Pictured: Pfizer's signage outside its office in Canada/iStock, JHVEPhoto

Layoffs

Pfizer’s Cost Cuts Claim 200+ Jobs in Switzerland: Report

December 11, 2025

·

2 min read

·

Tristan Manalac